Evidence map›Paper›PMID 40872546›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Systemic Metabolic Alterations Induced by Etodolac in Healthy Individuals.

Rajaa Sebaa, Reem H AlMalki, Hatouf Sukkarieh, Lina A Dahabiyeh, Maha Al Mogren, Tawfiq Arafat, Ahmed H Mujamammi, Essa M Sabi, Anas M Abdel Rahman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rajaa SebaaDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.ORCID 0000-0003-3638-8716
Reem H AlMalkiMetabolomics Section, Precision Medicine Laboratory Department, Genomics Medicine Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Hatouf SukkariehDepartment of Pharmacology, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0000-0003-3736-5989
Lina A DahabiyehDepartment of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11972, Jordan.
Maha Al MogrenMetabolomics Section, Precision Medicine Laboratory Department, Genomics Medicine Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.ORCID 0000-0002-2244-6842
Tawfiq ArafatJordan Center for Pharmaceutical Research (JCPR), Amman 11118, Jordan.ORCID 0000-0002-8483-6985
Ahmed H MujamammiClinical Biochemistry Unit, Pathology Department, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Essa M SabiClinical Biochemistry Unit, Pathology Department, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0001-8266-5177
Anas M Abdel RahmanMetabolomics Section, Precision Medicine Laboratory Department, Genomics Medicine Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.ORCID 0000-0002-9527-9424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EtodolacLC/MS-based untargeted metabolomicsmetabolic alterationsmetabolic pathwaysmetabolic profiling

Identifiers

PMID40872546
PMCPMC12388885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.